epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

lasuna

garlic (Allium sativum)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • allergic rhinitis [Insufficient Evidence]
  • alopecia areata [Insufficient Evidence]
  • angina, unstable [Insufficient Evidence]
  • asthma [Insufficient Evidence]
  • atherosclerosis [Possibly Effective]
  • athletic performance [Insufficient Evidence]
  • bladder CA [Insufficient Evidence]
  • BPH [Insufficient Evidence]
  • bronchitis [Insufficient Evidence]
  • cancer prevention, breast [Insufficient Evidence]
  • cancer prevention, colorectal [Insufficient Evidence]
  • cancer prevention, esophageal [Insufficient Evidence]
  • cancer prevention, gastric [Possibly Ineffective]
  • cancer prevention, lung [Insufficient Evidence]
  • candidiasis, oropharyngeal [Insufficient Evidence]
  • candidiasis, vulvovaginal [Insufficient Evidence]
  • cardiovascular disease [Insufficient Evidence]
  • chronic fatigue syndrome [Insufficient Evidence]
  • common cold [Insufficient Evidence]
  • corns [Insufficient Evidence]
  • coronary heart disease [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • cystic fibrosis [Insufficient Evidence]
  • dental hypersensitivity [Insufficient Evidence]
  • denture stomatitis [Insufficient Evidence]
  • diabetes mellitus [Possibly Effective]
  • diabetic retinopathy [Insufficient Evidence]
  • diarrhea [Insufficient Evidence]
  • dysmenorrhea [Insufficient Evidence]
  • endometriosis [Possibly Effective]
  • erectile dysfunction [Insufficient Evidence]
  • exercise-induced muscle soreness [Insufficient Evidence]
  • familial hypercholesterolemia [Insufficient Evidence]
  • fatigue [Insufficient Evidence]
  • fibrocystic breast disease [Insufficient Evidence]
  • gastritis [Insufficient Evidence]
  • gout [Insufficient Evidence]
  • hepatitis [Insufficient Evidence]
  • hepatopulmonary syndrome [Insufficient Evidence]
  • H. pylori infection [Possibly Ineffective]
  • HTN [Possibly Effective]
  • hyperlipidemia [Possibly Effective]
  • influenza [Insufficient Evidence]
  • lead toxicity [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Possibly Effective]
  • metabolic syndrome [Insufficient Evidence]
  • mosquito repellent [Insufficient Evidence]
  • multiple myeloma [Insufficient Evidence]
  • muscle strength [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • onychomycosis [Insufficient Evidence]
  • osteoarthritis [Insufficient Evidence]
  • otitis media [Insufficient Evidence]
  • periodontitis [Possibly Effective]
  • peripheral arterial disease [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • pre-eclampsia [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • prostate CA [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • scleroderma [Insufficient Evidence]
  • stress [Insufficient Evidence]
  • tick repellent [Insufficient Evidence]
  • tinea capitis [Insufficient Evidence]
  • tinea corporis [Insufficient Evidence]
  • tinea cruris [Insufficient Evidence]
  • tinea pedis [Insufficient Evidence]
  • trichomoniasis [Insufficient Evidence]
  • tuberculosis [Insufficient Evidence]
  • UTI [Insufficient Evidence]
  • warts [Insufficient Evidence]
  • wound healing [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information